Ian Sacks - 20 Sep 2022 Form 4 Insider Report for HEALTHEQUITY, INC. (HQY)

Role: Director
Signature: /s/ Delano W. Ladd, Attorney-in-Fact
Issuer symbol: HQY
Transactions as of: 20 Sep 2022
Net transactions value: -$1,806,925
Form type: 4
Filing time: 22 Sep 2022, 16:41:00 UTC
Previous filing: 27 Jun 2022
Next filing: 21 Oct 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	HQY	Common Stock	Sale	$1,806,925	-25,000	-16%	$72.28	126,570	20 Sep 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	HQY	Stock Option (right to buy)	15,000	20 Sep 2022	Common Stock	15,000	$21.27	Direct	F2
holding	HQY	Stock Option (right to buy)	15,000	20 Sep 2022	Common Stock	15,000	$14.00	Direct	F2
holding	HQY	Stock Option (right to buy)	15,000	20 Sep 2022	Common Stock	15,000	$25.39	Direct	F2
holding	HQY	Stock Option (right to buy)	8,024	20 Sep 2022	Common Stock	8,024	$66.06	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $72.15 to $72.87 inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) of this Form 4.
F2	The option is immediately exercisable.

Content

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $72.15 to $72.87 inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) of this Form 4.

The option is immediately exercisable.

Remarks:

The power of Attorney given by Mr. Sacks was previously filed with the U.S. Securities and Exchange Commission on February 3, 2017 as an exhibit to a statement on Form 4 filed by Mr. Sacks with respect to HealthEquity, Inc. and is hereby incorporated by reference.